In Vitro Susceptibility of Varicella Zoster Virus to Adenine Arabinoside and Hypoxanthine Arabinoside
- 1 March 1976
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 9 (3) , 540-543
- https://doi.org/10.1128/aac.9.3.540
Abstract
The in vitro susceptibility of varicella zoster (VZ) isolates to adenine arabinoside (ara-A) and hypoxanthine arabinoside (ara-Hx) was determined in human skin fibroblasts. Using a system in which deamination was inhibited, and using a modified plaque reduction method, the antiviral activities of ara-A and ara-Hx were separated. The plaque inhibitory concentration of ara-A for all VZ isolates tested was 1 to 2 μg/ml and 80 to 100 μg/ml for ara-Hx. A comparison of antiviral activity based upon total plaque suppression gave a rate of 40 to 50:1, in favor of ara-A.Keywords
This publication has 9 references indexed in Scilit:
- Treatment of Varicella-Zoster Virus Infections with Adenine ArabinosideThe Journal of Infectious Diseases, 1975
- Effect of Adenosine Deaminase upon the Antiviral Activity In Vitro of Adenine Arabinoside for Vaccinia VirusAntimicrobial Agents and Chemotherapy, 1974
- Observations on the Growth of Varicella-Zoster Virus in Human Diploid CellsJournal of General Virology, 1973
- The Antiviral Activity of 9-β-D-Arabinofuranosyladenine (ARA-A)Chemotherapy, 1968
- A New Member of the Herpesvirus Group Isolated from South American MarmosetsThe Journal of Immunology, 1964
- Inhibition of Varicella Virus by 5-Iodo-2'-deoxyuridineExperimental Biology and Medicine, 1964
- Plaque Assay for Measurement of Cells Infected with Zoster VirusScience, 1963
- THE ETIOLOGIC AGENTS OF VARICELLA AND HERPES ZOSTERThe Journal of Experimental Medicine, 1958
- Serial Propagation in vitro of Agents Producing Inclusion Bodies Derived from Varicella and Herpes Zoster.Experimental Biology and Medicine, 1953